Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Torrent Pharmaceuticals had annual revenue of 139.80B INR with 21.39% growth. Torrent Pharmaceuticals had revenue of 41.97B in the quarter ending March 31, 2026, with 41.83% growth.

• Revenue: 139.80B
• Revenue Growth: +21.39%
• P/S Ratio: 11.08
• Revenue / Employee: 7.66M
• Employees: 18,258
• Market Cap: 1.55T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	139.80B	24.64B	21.39%
Mar 31, 2025	115.16B	7.88B	7.35%
Mar 31, 2024	107.28B	11.08B	11.51%
Mar 31, 2023	96.20B	11.12B	13.07%
Mar 31, 2022	85.08B	5.03B	6.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error